10-K Filing

LifeMD, Inc. CIK: 948320 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0001493152-24-009581`
Period End Date	20231231
Filing Date	20240311
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	form10-k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 87 Income Statement 50 Cash Flow Statement 117 Stockholders Equity 34

Balance Sheet 87 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashAndCashEquivalentsAtCarryingValue`	$3.96M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$33.15M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$5.28M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$2.83M	USD	Point-in-time
Product deposit	`DepositsAssetsCurrent`	$485.85K	USD	Point-in-time
Product deposit	`DepositsAssetsCurrent`	$127.27K	USD	Point-in-time
Inventory, net	`InventoryNet`	$2.76M	USD	Point-in-time
Inventory, net	`InventoryNet`	$3.70M	USD	Point-in-time
Temporary equity, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$687.02K	USD	Point-in-time
Temporary equity, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$934.51K	USD	Point-in-time
Temporary equity, shares authorized	`TemporaryEquitySharesAuthorized`	5.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$42.60M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$11.31M	USD	Point-in-time
Temporary equity, shares authorized	`TemporaryEquitySharesAuthorized`	5.00M	shares	Point-in-time
Equipment, net	`PropertyPlantAndEquipmentNet`	$476.30K	USD	Point-in-time
Equipment, net	`PropertyPlantAndEquipmentNet`	$476.44K	USD	Point-in-time
Series A preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$594.90K	USD	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$1.21M	USD	Point-in-time
Capitalized software, net	`CapitalizedComputerSoftwareNet`	$11.80M	USD	Point-in-time
Capitalized software, net	`CapitalizedComputerSoftwareNet`	$8.84M	USD	Point-in-time
Series A preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$3.83M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$3.01M	USD	Point-in-time
Total Non-current Assets	`AssetsNoncurrent`	$15.88M	USD	Point-in-time
Total Non-current Assets	`AssetsNoncurrent`	$14.35M	USD	Point-in-time
Total Assets	`Assets`	$58.48M	USD	Point-in-time
Total Assets	`Assets`	$25.67M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	38.36M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	31.55M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.08M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.11M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	31.45M	shares	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$13.94M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	38.26M	shares	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$12.17M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockCommonShares`	103,040.00	shares	Point-in-time
Notes payable, net	`NotesPayableCurrent`	$327.60K	USD	Point-in-time
Treasury stock, shares	`TreasuryStockCommonShares`	103,040.00	shares	Point-in-time
Notes payable, net	`NotesPayableCurrent`	$2.80M	USD	Point-in-time
Current operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$756.09K	USD	Point-in-time
Current operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$603.18K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$5.55M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$1.50M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$8.83M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$34.78M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$31.37M	USD	Point-in-time
Long-term debt, net	`ConvertibleDebtNoncurrent`	$17.93M	USD	Point-in-time
Long-term debt, net	`ConvertibleDebtNoncurrent`	-	USD	Point-in-time
Noncurrent operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$73.85K	USD	Point-in-time
Noncurrent operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$574.14K	USD	Point-in-time
Contingent consideration	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$443.75K	USD	Point-in-time
Contingent consideration	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$131.25K	USD	Point-in-time
Purchase price payable	`PurchasePricePayable`	-	USD	Point-in-time
Purchase price payable	`PurchasePricePayable`	$579.32K	USD	Point-in-time
Total Liabilities	`Liabilities`	$32.97M	USD	Point-in-time
Total Liabilities	`Liabilities`	$52.91M	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred Stock, $0.0001 par value; 5,000,000 shares authorized Series B Convertible Preferred Stock, $0.0001 par value; 5,000 shares authorized, zero and 3,500 shares issued and outstanding, liquidation value approximately, $0 and $1,305 per share as of December 31, 2023 and 2022, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	-	USD	Point-in-time
Preferred Stock, $0.0001 par value; 5,000,000 shares authorized Series B Convertible Preferred Stock, $0.0001 par value; 5,000 shares authorized, zero and 3,500 shares issued and outstanding, liquidation value approximately, $0 and $1,305 per share as of December 31, 2023 and 2022, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$4.57M	USD	Point-in-time
Series A Preferred Stock, $0.0001 par value; 1,610,000 shares authorized, 1,400,000 shares issued and outstanding, liquidation value approximately, $29.99 and $27.84 per share as of December 31, 2023 and 2022, respectively	`PreferredStockValue`	$140.00	USD	Point-in-time
Series A Preferred Stock, $0.0001 par value; 1,610,000 shares authorized, 1,400,000 shares issued and outstanding, liquidation value approximately, $29.99 and $27.84 per share as of December 31, 2023 and 2022, respectively	`PreferredStockValue`	$140.00	USD	Point-in-time
Common Stock, $0.01 par value; 100,000,000 shares authorized, 38,358,641 and 31,552,775 shares issued, 38,255,601 and 31,449,735 outstanding as of December 31, 2023 and 2022, respectively	`CommonStockValue`	$315.53K	USD	Point-in-time
Common Stock, $0.01 par value; 100,000,000 shares authorized, 38,358,641 and 31,552,775 shares issued, 38,255,601 and 31,449,735 outstanding as of December 31, 2023 and 2022, respectively	`CommonStockValue`	$383.59K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$179.02M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$217.55M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-190.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-214.27M	USD	Point-in-time
Treasury stock, 103,040 and 103,040 shares, at cost, as of December 31, 2023 and 2022, respectively	`TreasuryStockValue`	$163.70K	USD	Point-in-time
Treasury stock, 103,040 and 103,040 shares, at cost, as of December 31, 2023 and 2022, respectively	`TreasuryStockValue`	$163.70K	USD	Point-in-time
Total LifeMD, Inc. Stockholders Equity (Deficit)	`StockholdersEquity`	$3.51M	USD	Point-in-time
Total LifeMD, Inc. Stockholders Equity (Deficit)	`StockholdersEquity`	$-11.40M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-475.55K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$2.06M	USD	Point-in-time
Total Stockholders Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$21.71M	USD	Point-in-time
Total Stockholders Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.57M	USD	Point-in-time
Total Stockholders Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-11.87M	USD	Point-in-time
Total Liabilities, Mezzanine Equity and Stockholders Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$58.48M	USD	Point-in-time
Total Liabilities, Mezzanine Equity and Stockholders Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$25.67M	USD	Point-in-time

Income Statement 50 line items

Line Item	Tag	Value	Unit	Period
Total revenues, net	`RevenueFromContractWithCustomerExcludingAssessedTax`	$152.55M	USD	Annual
Total revenues, net	`RevenueFromContractWithCustomerExcludingAssessedTax`	$119.03M	USD	Annual
Total cost of revenues	`CostOfRevenue`	$18.90M	USD	Annual
Total cost of revenues	`CostOfRevenue`	$18.67M	USD	Annual
Gross profit	`GrossProfit`	$100.37M	USD	Annual
Gross profit	`GrossProfit`	$133.65M	USD	Annual
Selling and marketing expenses	`SellingAndMarketingExpense`	$76.45M	USD	Annual
Selling and marketing expenses	`SellingAndMarketingExpense`	$78.37M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$46.96M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$51.69M	USD	Annual
Other operating expenses	`OtherGeneralExpense`	$6.72M	USD	Annual
Other operating expenses	`OtherGeneralExpense`	$6.30M	USD	Annual
Customer service expenses	`OtherSellingGeneralAndAdministrativeExpense`	$7.63M	USD	Annual
Customer service expenses	`OtherSellingGeneralAndAdministrativeExpense`	$5.03M	USD	Annual
Development costs	`DevelopmentCosts`	$2.97M	USD	Annual
Development costs	`DevelopmentCosts`	$6.06M	USD	Annual
Goodwill and intangible asset impairment charges	`GoodwillAndIntangibleAssetImpairment`	-	USD	Annual
Goodwill and intangible asset impairment charges	`GoodwillAndIntangibleAssetImpairment`	$8.86M	USD	Annual
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$5.10M	USD	Annual
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	-	USD	Annual
Total expenses	`OperatingExpenses`	$148.14M	USD	Annual
Total expenses	`OperatingExpenses`	$143.81M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-43.45M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-14.49M	USD	Annual
Interest expense, net	`InterestExpense`	$1.28M	USD	Annual
Interest expense, net	`InterestExpense`	$2.60M	USD	Annual
(Loss) gain on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-325.20K	USD	Annual
(Loss) gain on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$63.40K	USD	Annual
Loss from operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-17.41M	USD	Annual
Loss from operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-44.66M	USD	Annual
Income tax provision	`IncomeTaxExpenseBenefit`	$428.00K	USD	Annual
Income tax provision	`IncomeTaxExpenseBenefit`	$360.70K	USD	Annual
Net loss	`ProfitLoss`	$-45.02M	USD	Annual
Net loss	`ProfitLoss`	$-17.84M	USD	Annual
Net income attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$514.63K	USD	Annual
Net income attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.76M	USD	Annual
Net loss attributable to LifeMD, Inc.	`NetIncomeLoss`	$-45.54M	USD	Annual
Net loss attributable to LifeMD, Inc.	`NetIncomeLoss`	$-20.60M	USD	Annual
Preferred stock dividends	`PreferredStockDividendsIncomeStatementImpact`	$3.11M	USD	Annual
Preferred stock dividends	`PreferredStockDividendsIncomeStatementImpact`	$3.11M	USD	Annual
Net loss attributable to LifeMD, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-48.64M	USD	Annual
Net loss attributable to LifeMD, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.70M	USD	Annual
Basic loss per share attributable to LifeMD, Inc. common stockholders	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.57	USD	Annual
Basic loss per share attributable to LifeMD, Inc. common stockholders	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.70	USD	Annual
Diluted loss per share attributable to LifeMD, Inc. common stockholders	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.57	USD	Annual
Diluted loss per share attributable to LifeMD, Inc. common stockholders	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.70	USD	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	33.91M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	30.98M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.98M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	33.91M	shares	Annual

Cash Flow Statement 117 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-45.02M	USD	Annual
Net loss	`ProfitLoss`	$-17.84M	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$333.94K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Amortization of capitalized software	`CapitalizedComputerSoftwareAmortization1`	$2.68M	USD	Annual
Amortization of capitalized software	`CapitalizedComputerSoftwareAmortization1`	$5.42M	USD	Annual
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$971.46K	USD	Annual
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$926.54K	USD	Annual
Accretion of consideration payable	`AccretionExpenseIncludingAssetRetirementObligations`	$273.82K	USD	Annual
Accretion of consideration payable	`AccretionExpenseIncludingAssetRetirementObligations`	$167.22K	USD	Annual
Depreciation of fixed assets	`Depreciation`	$203.95K	USD	Annual
Depreciation of fixed assets	`Depreciation`	$161.88K	USD	Annual
Write-down of inventory	`InventoryWriteDown`	$537.68K	USD	Annual
Write-down of inventory	`InventoryWriteDown`	$103.42K	USD	Annual
Sales return reserve	`SalesReturnsReserve`	$338.19K	USD	Annual
Sales return reserve	`SalesReturnsReserve`	-	USD	Annual
Loss (gain) on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-325.20K	USD	Annual
Loss (gain) on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$63.40K	USD	Annual
Change in fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	-	USD	Annual
Change in fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-5.10M	USD	Annual
Goodwill and intangible asset impairment charges	`GoodwillAndIntangibleAssetImpairment`	-	USD	Annual
Goodwill and intangible asset impairment charges	`GoodwillAndIntangibleAssetImpairment`	$8.86M	USD	Annual
Deferred income tax provision	`DeferredIncomeTaxExpenseBenefit`	$354.00K	USD	Annual
Deferred income tax provision	`DeferredIncomeTaxExpenseBenefit`	-	USD	Annual
Operating lease payments	`OperatingLeasePaymentsAdjustments`	$766.28K	USD	Annual
Operating lease payments	`OperatingLeasePaymentsAdjustments`	$546.44K	USD	Annual
Stock issued for legal settlement	`StockIssuedForLegalSettlement`	$816.00K	USD	Annual
Stock issued for legal settlement	`StockIssuedForLegalSettlement`	$532.00K	USD	Annual
Stock compensation expense	`ShareBasedCompensation`	$13.73M	USD	Annual
Stock compensation expense	`ShareBasedCompensation`	$12.49M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.44M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.19M	USD	Annual
Product deposit	`IncreaseDecreaseInContractWithCustomerAsset`	$-76.29K	USD	Annual
Product deposit	`IncreaseDecreaseInContractWithCustomerAsset`	$358.58K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-405.75K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$2.18M	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$247.49K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-106.17K	USD	Annual
Change in operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-808.37K	USD	Annual
Change in operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-455.81K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$4.05M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$3.28M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.25M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$978.06K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$4.68M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.31M	USD	Annual
Other operating activity	`IncreaseDecreaseInOtherOperatingLiabilities`	$-579.32K	USD	Annual
Other operating activity	`IncreaseDecreaseInOtherOperatingLiabilities`	$-888.49K	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-22.94M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$8.82M	USD	Annual
Cash paid for capitalized software costs	`PaymentsToAcquireSoftware`	$8.38M	USD	Annual
Cash paid for capitalized software costs	`PaymentsToAcquireSoftware`	$8.53M	USD	Annual
Purchase of equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$366.63K	USD	Annual
Purchase of equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$203.81K	USD	Annual
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$148.87K	USD	Annual
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$4.00M	USD	Annual
Acquisition of business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Acquisition of business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.01M	USD	Annual
Acquisition of business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$460.00K	USD	Point-in-time
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-13.91M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.73M	USD	Annual
Proceeds from long-term debt, net	`ProceedsFromConvertibleDebt`	$19.47M	USD	Annual
Proceeds from long-term debt, net	`ProceedsFromConvertibleDebt`	-	USD	Annual
Cash proceeds from common stock issued to Medifast	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Cash proceeds from common stock issued to Medifast	`ProceedsFromIssuanceOfCommonStock`	$10.00M	USD	Annual
Proceeds from notes payable	`ProceedsFromNotesPayable`	$2.91M	USD	Annual
Proceeds from notes payable	`ProceedsFromNotesPayable`	$2.35M	USD	Annual
Sale of common stock under ATM, net	`SaleOfCommonStock`	-	USD	Annual
Sale of common stock under ATM, net	`SaleOfCommonStock`	$6.20M	USD	Annual
Cash proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$38.50K	USD	Annual
Cash proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	Annual
Cash proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$90.40K	USD	Annual
Cash proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$94.50K	USD	Annual
Preferred stock dividends	`PaymentsOfDividends`	$3.11M	USD	Annual
Preferred stock dividends	`PaymentsOfDividends`	$3.11M	USD	Annual
Net payments for membership interest in WorkSimpli	`NetPaymentsForMembershipInterestInWorksimpli`	$-305.62K	USD	Annual
Net payments for membership interest in WorkSimpli	`NetPaymentsForMembershipInterestInWorksimpli`	$12.15K	USD	Annual
Contingent consideration payments for ResumeBuild acquisition	`PaymentsToAcquireProductiveAsset`	$312.50K	USD	Annual
Contingent consideration payments for ResumeBuild acquisition	`PaymentsToAcquireProductiveAsset`	$156.25K	USD	Annual
Distributions to non-controlling interest	`PaymentsToMinorityShareholders`	$144.00K	USD	Annual
Distributions to non-controlling interest	`PaymentsToMinorityShareholders`	$144.00K	USD	Annual
Repayment of notes payable, net of prepayment penalty	`RepaymentsOfNotesPayable`	$168.75K	USD	Annual
Repayment of notes payable, net of prepayment penalty	`RepaymentsOfNotesPayable`	$5.14M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-528.20K	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$29.10M	USD	Annual
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$29.19M	USD	Annual
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-37.37M	USD	Annual
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$41.33M	USD	Point-in-time
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.96M	USD	Point-in-time
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$33.15M	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$41.33M	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.96M	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$33.15M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$189.00K	USD	Annual
Cash paid during the period for interest	`InterestPaidNet`	$2.15M	USD	Annual
Cashless exercise of options	`CashlessExerciseOfOptions`	$297.00	USD	Annual
Cashless exercise of options	`CashlessExerciseOfOptions`	$744.00	USD	Annual
Cashless exercise of warrants	`CashlessExerciseOfWarrants`	$793.00	USD	Annual
Cashless exercise of warrants	`CashlessExerciseOfWarrants`	-	USD	Annual
Consideration payable for Cleared acquisition	`ConsiderationPayableForClearedAcquisition`	-	USD	Annual
Consideration payable for Cleared acquisition	`ConsiderationPayableForClearedAcquisition`	$8.08M	USD	Annual
Consideration payable for ResumeBuild acquisition	`ConsiderationPayableForResumebuildAcquisition`	$500.00K	USD	Annual
Consideration payable for ResumeBuild acquisition	`ConsiderationPayableForResumebuildAcquisition`	-	USD	Annual
Stock issued for noncontingent consideration payments	`StockIssued1`	$2.57M	USD	Annual
Stock issued for noncontingent consideration payments	`StockIssued1`	-	USD	Annual
Stock issued for debt conversion	`StockIssuedForDebtConversion`	-	USD	Annual
Stock issued for debt conversion	`StockIssuedForDebtConversion`	$1.00M	USD	Annual
Series B Preferred Stock conversion	`SeriesBPreferredStockConversion`	$5.07M	USD	Annual
Series B Preferred Stock conversion	`SeriesBPreferredStockConversion`	-	USD	Annual
Principal of Paycheck Protection Program loans forgiven	`PrincipalOfPaycheckProtectionProgramLoansForgiven`	-	USD	Annual
Principal of Paycheck Protection Program loans forgiven	`PrincipalOfPaycheckProtectionProgramLoansForgiven`	$63.40K	USD	Annual
Warrants issued for debt instruments	`NonCashWarrantsIssuedForDebtInstruments`	$873.10K	USD	Annual
Warrants issued for debt instruments	`NonCashWarrantsIssuedForDebtInstruments`	-	USD	Annual
Right of use asset	`RightOfUseAsset`	$155.17K	USD	Annual
Right of use asset	`RightOfUseAsset`	$89.59K	USD	Annual
Right of use lease liability	`CapitalLeaseObligationsIncurred`	$155.17K	USD	Annual
Right of use lease liability	`CapitalLeaseObligationsIncurred`	$94.17K	USD	Annual

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$21.71M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.57M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-11.87M	USD	Point-in-time
Stock compensation expense	`StockIssuedDuringPeriodValueShareBasedCompensation`	$13.73M	USD	Annual
Stock compensation expense	`StockIssuedDuringPeriodValueShareBasedCompensation`	$12.49M	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$94.50K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$90.40K	USD	Annual
Exercise of stock options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	37,500.00	shares	Annual
Exercise of stock options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	90,400.00	shares	Annual
Exercise of warrants	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$38.50K	USD	Annual
Cashless exercise of stock options	`StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions`	-	USD	Annual
Cashless exercise of stock options	`StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions`	-	USD	Annual
Stock issued for legal settlement	`StockIssuedDuringPeriodValueLegalSettlement`	$816.00K	USD	Annual
Series A Preferred Stock dividends	`StockIssuedDuringPeriodValueStockDividend`	$3.11M	USD	Annual
Series A Preferred Stock dividends	`StockIssuedDuringPeriodValueStockDividend`	$3.11M	USD	Annual
Distribution to non-controlling interest	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$144.00K	USD	Annual
Distribution to non-controlling interest	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$144.00K	USD	Annual
Adjustment of membership interest in WorkSimpli	`AdjustmentsToAdditionalPaidInCapitalOther`	$-305.62K	USD	Annual
Adjustment of membership interest in WorkSimpli	`AdjustmentsToAdditionalPaidInCapitalOther`	$12.15K	USD	Annual
Net (loss) income	`ProfitLoss`	$-45.02M	USD	Annual
Net (loss) income	`ProfitLoss`	$-17.84M	USD	Annual
Cashless exercise of warrants	`StockIssuedDuringPeriodValueCashlessExerciseOfStockWarrants`	-	USD	Annual
Stock issued for noncontingent consideration payments	`StockIssuedDuringPeriodValueNoncontingentConsiderationPayment`	$2.57M	USD	Annual
Stock issued for legal settlement	`StockIssuedDuringPeriodValueOther`	$532.00K	USD	Annual
Stock issued for legal settlement, shares	`StockIssuedDuringPeriodSharesOther`	400,000.00	shares	Annual
Warrants issued with debt instrument	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$873.10K	USD	Annual
Sale of common stock under ATM, net	`SaleOfCommonStockUnderAtmNet`	$6.20M	USD	Annual
Stock issued for debt conversion	`StockIssuedForDebtInstruments`	$1.00M	USD	Annual
Common stock issued to Medifast	`StockIssuedDuringPeriodValueIssuedForServices`	$10.00M	USD	Annual
Common stock issued to Medifast, shares	`StockIssuedDuringPeriodSharesIssuedForServices`	306,250.00	shares	Annual
Series B Preferred Stock conversion	`StockIssuedDuringPeriodValueLegalPreferredStockConversion`	$-5.07M	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$21.71M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.57M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-11.87M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.